Success Story: NIW Victory Without an RFE for A Postdoctoral Scholar from China in Just Over 5 Months
Client’s Testimonial:
"It's really good news, and thank you so much for the preparation."
On January 31st, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Synthetic Organic Chemistry (Approval Notice).
General Field: Synthetic Organic Chemistry
Position at the Time of Case Filing: Postdoctoral Scholar
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: January 31st, 2026
Processing Time: 5 months and 3 days
Case Summary:
"Therefore, [Client]'s review service illustrates his recognition as an expert in the synthetic organic chemistry research community."
The statement above is taken from one of two recommendation letters submitted as part of the EB-2 NIW (National Interest Waiver) petition for a researcher from China holding a Ph.D. in organic chemistryClient Background and Proposed Endeavor
As a postdoctoral scholar in the field of chemistry, the proposed endeavor is to continue developing novel synthetic methods and complex bioactive compound synthesis. With extensive training in polycyclic compound construction, metal-catalyzed reaction development, and pharmaceutical molecule synthesis, this scientist is actively advancing groundbreaking research in the rapid synthesis of complex molecular compounds with direct applications to drug discovery and therapeutic innovation.
National Significance of the Research
We emphasized that this research is of significant importance and has far-reaching implications for the United States. The work directly addresses the urgent need for more efficient pharmaceutical synthesis methods, strengthening healthcare and pharmaceutical innovation nationwide.
This research develops innovative methodologies that utilize readily available starting materials to enable rapid generation of structurally complex compounds, identifies efficient synthetic routes for drug-like small molecules, and reduces costs and time required for pharmaceutical development. Additionally, the findings align with U.S. pharmaceutical competitiveness goals and advance progress in therapeutic intervention development.
Impressive Credentials and Achievements
To further strengthen the case, we highlighted exceptional credentials:
- Publications: An impressive portfolio of 6 peer-reviewed journal articles (5 of them first- or co-first-authored) and 1 first-authored preprint.
- Citations: The work has been cited 164 times.
- Peer Review Service: The client has been invited to conduct peer reviews for leading chemistry journals and has completed at least 32 reviews to date.
- Competitive Funding: The research has been supported by major funding sources, including the Natural Science Foundation of China, affirming the significance and national importance of the work.
Considering the exceptional strength of the accomplishments and the national importance of the proposed endeavor, we are delighted to share that this NIW petition was approved in just over 5 months without an RFE. The innovative work in synthetic organic chemistry and pharmaceutical molecule synthesis, combined with demonstrated expertise in novel methodologies and efficient compound construction, positions this researcher to make transformative contributions to U.S. pharmaceutical innovation and healthcare advancement for years to come.